General
Oxford University to launch trial alternating coronavirus vaccines from AstraZeneca and Pfizer-BioNTech
Oxford University says it will launch a trial alternating doses of COVID-19 vaccines created by different manufacturers.
Key points:
- The trial aims to determine whether different COVID-19 doses can be used interchangeably
- If successful, it could lead to a more flexible vaccine rollout, says the UK’s chief health officer
- Britain has been administering vaccines at an interval of 12 weeks to give more people a first dose, unlike other countries
The trial aims to determine whether different COVID-19 vaccine doses — those created by the AstraZeneca and Pfizer-BioNTech pharmaceutical companies — can be used interchangeably.
If successful it could allow greater flexibility in pressured vaccine delivery schedules.
The UK’s Deputy Chief Medical…
Continue Reading
-
Noosa News24 hours agoInside the final hours before Australian lawyer Christopher Saines died in Thai massage parlour
-
General22 hours agoGerman backpacker Carolina Wilga found alive in WA’s outback
-
Noosa News24 hours agoGrow it local | Noosa Today
-
General11 hours agoThailand punches above its weight in film creativity and cross-border appeal. Here’s why